Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00766727
Other study ID # CA001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2008
Est. completion date March 2010

Study information

Verified date December 2020
Source Neodyne Biosciences, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will evaluate a new dressing to be used for post-incision care for abdominoplasty patients. The hypothesis is that this dressing will minimize scar formation.


Description:

This study will evaluate a new dressing in up to 30 patients who have undergone an abdominoplasty procedure. They will wear the dressing through 8 weeks post surgery and the scar will be evaluated at 3 months post surgery.


Recruitment information / eligibility

Status Completed
Enrollment 12
Est. completion date March 2010
Est. primary completion date November 2009
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - subjects who have undergone an abdominoplasty 1 week prior to study participation Exclusion Criteria: - subjects with a history of collagen vascular disease or scleroderma - subjects with known adverse reactions to steri-strips, medical tapes or adhesives

Study Design


Related Conditions & MeSH terms

  • Post Surgical Incisions From Abdominoplasty Procedures
  • Surgical Wound

Intervention

Device:
GLYDe Dressing
Wound dressing intended to minimize scar formation

Locations

Country Name City State
United States Josh Korman, MD Mountain View California

Sponsors (1)

Lead Sponsor Collaborator
Neodyne Biosciences, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Scar Evaluation at End of Treatment Period Comparing Treated to Standard of Care (Control) Professional photographs were taken 12 months postsurgery and evaluated by lay and professional panels. A 100 point Visual Analog Scale (VAS), ranging from a score of 0 for a better outcome to a score of 100 for worse outcome, will be used to assess both the Treated and Control scars at the same timepoint. through 12 months